Author: Omkar Sai Niranjan Turlapati

Medical Blog Writer, Content & Marketing Specialist

Post Amputation Pain, phantom limb pain, residual limb pain, musculoskeletal pain, lower limb amputation, prosthetic design, socket prosthesis, osseointegration prosthesis, bone anchored limb, limb loss rehabilitation, prosthetics research, gait mechanics, rehabilitation medicine, amputation care, physical medicine research, prosthetics research study, amputation pain management, rehabilitation medicine limb loss, limb restoration therapy
Post Amputation Pain Patterns Differ by Prosthetic Type

Key Summary A new study from the University of Colorado Anschutz Medical Campus shows that.

Diabetic Kidney Disease, senescent cells, zombie cells, senolytic therapy, dasatinib quercetin therapy, kidney inflammation, chronic kidney disease research, diabetes complications, nephrology research, kidney function improvement, cellular senescence, Mayo Clinic research, kidney disease treatment, renal inflammation, diabetes kidney damage, cellular senescence treatment, nephrology research study, kidney damage diabetes, renal inflammation therapy, senolytics diabetic kidney disease, kidney health diabetes, diabetes complications kidney
Diabetic Kidney Disease: Combo Therapy Targets Zombie Cells

Key Points Researchers from Mayo Clinic identified a combination therapy that may reduce harmful senescent.

Heart Attack Recovery, myocardial infarction treatment, saRNA therapy, atrial natriuretic peptide, cardiac repair research, RNA therapeutics, cardiovascular research, ANP hormone therapy, heart failure prevention, cardiac healing therapy, cardiology innovation, cardiovascular medicine, heart disease treatment, RNA medicine, post heart attack care, RNA therapeutics cardiology, NPR1 signaling pathway, cardiac stress reduction, heart muscle repair, post heart attack therapy, cardiovascular research innovation, heart disease treatment
Heart Attack Recovery: Single Injection May Heal the Heart

Key Points Researchers have developed a single injection therapy that may support healing after a.

Fragmentome Technology, Liver Fibrosis Detection, Cirrhosis Screening, AI Liquid Biopsy, Cell-Free DNA, cfDNA Fragmentation, Genome-Wide Sequencing, Chronic Liver Disease, Hepatology Research, Cancer Prevention, Machine Learning in Medicine, Comorbidity Index, Precision Medicine, Translational Medicine, Early Disease Detection, liver disease biomarkers, liver fibrosis blood test, machine learning in hepatology, noninvasive liver disease diagnosis, comorbidity index prediction, cirrhosis risk assessment, precision medicine liver disease, translational medicine research
Fragmentome Technology Detects Early Liver Fibrosis

Key Points at a Glance AI-based fragmentome technology detects early liver fibrosis and cirrhosis using.

Healthy Aging, Joyful Dance Programs for Older Adults, Dance for Healthy Aging, Community-Based Dance, Older Adult Health, Social Prescribing, Active Aging, Geriatric Care, Nursing Practice, Emotional Well-Being, Inclusive Health Programs, Public Health Aging, Movement Therapy, Cognitive Health, Senior Wellness, Arts-Based Research, geriatric wellness programs, emotional well-being in seniors, cognitive health and dance, senior community health, movement therapy for aging, holistic aging care, accessible exercise for seniors, aging and social connection
Dance for Healthy Aging: Study Highlights Benefits

Key Points at a Glance A qualitative study of Canada’s Sharing Dance Older Adults program.

Breast Cancer, Triple Negative Breast Cancer, High Fat Diet, Cancer Metabolism, Tumor Microenvironment, MMP1, Oncology Research, Precision Oncology, Dietary Conditions, Chemotherapy Response, Extracellular Matrix, Cancer Prognosis, Tumor Invasion, Nutritional Oncology, Plasma-like Medium, tumor microenvironment, dietary conditions in cancer, oncology nutrition research, chemotherapy response and diet, plasma-like tumor model, metabolic reprogramming in cancer, TNBC prognosis factors, cancer cell invasion
Breast Cancer Prognosis Linked to High-Fat Diet

Key Points A high-fat diet accelerated tumor growth in TNBC models. Increased MMP1 levels are.

CTNNB1 Syndrome, rare diseases, neurodevelopmental disorders, beta-catenin, brain organoids, molecular biophysics, genetic research, neuroscience, AI in medicine, Spain research, CTNNB1 neurodevelopmental syndrome, beta-catenin, rare disease research, brain organoids, neurodevelopment, cell adhesion, cadherins, genetic mutations, molecular biology, biophysics, AI protein modeling, neuroscience research, synaptic plasticity, CSIC, EHU
CTNNB1 Syndrome Study Explores Beta-Catenin Defects

Key Takeaways Researchers in Spain are investigating the molecular basis of CTNNB1 Syndrome, a rare.

Advanced Prostate Cancer, Liquid biopsy, ctDNA testing, mCRPC, Androgen receptor alterations, Precision oncology, PARP inhibitors, AR pathway inhibitors, Treatment resistance, Genomic profiling, metastatic castration-resistant prostate cancer, ctDNA testing, androgen receptor alterations, AR amplification, treatment resistance, precision oncology, PARP inhibitors, ARPIs, taxane chemotherapy, real-time molecular testing, genomic instability, BRCA reversion mutations, personalized cancer care
Advanced Prostate Cancer and Serial ctDNA Analysis

Key Takeaways Serial liquid biopsies using ctDNA show how metastatic castration-resistant prostate cancer (mCRPC) changes.

Tuberculosis research, Experimental antibiotics, Drug-resistant TB, Mycobacterium tuberculosis, ClpC1 ClpP1P2, Antibiotic resistance, Infectious disease research, TB drug development, Proteomics, Antimicrobial therapy, experimental antibiotics for tuberculosis, drug-resistant TB, Mycobacterium tuberculosis, ClpC1 ClpP1P2 complex, tuberculosis treatment research, new TB drugs, antibiotic resistance, TB protein degradation, ecumicin ilamycin cyclomarin, infectious disease research, TB drug targets, antimicrobial research, tuberculosis bacteria, TB clinical research, global TB burden
Tuberculosis Breakthrough with Experimental Antibiotics

Key Takeaways Experimental antibiotics disrupt a vital protein degradation system in Mycobacterium tuberculosis Findings explain.

Healthy Longevity, VITAL-H Trial, ARPA-H Funding, Aging Research, Healthspan, Intrinsic Capacity, Geriatric Medicine, Preventive Care, FDA-Approved Drugs, Clinical Trials, healthy longevity clinical trial, aging research funding, ARPA-H PROSPR program, VITAL-H study, healthspan interventions, intrinsic capacity aging, FDA-approved drugs aging, rapamycin longevity, semaglutide aging, dapagliflozin healthspan, geriatric clinical trials, preventive aging medicine, wearable health monitoring, midlife aging study, longevity science
National Healthy Longevity Trial Receives Federal Support

Key Summary Up to $38 million in federal funding awarded to the Barshop Institute at.